WallStreetZenWallStreetZen

NASDAQ: THRD
Third Harmonic Bio Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for THRD

Based on 2 analysts offering 12 month price targets for Third Harmonic Bio Inc

Min Forecast
$5.00-7.92%
Avg Forecast
$5.00-7.92%
Max Forecast
$5.00-7.92%

Should I buy or sell THRD stock?

Based on 2 analysts offering ratings for Third Harmonic Bio Inc.

Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
2 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although THRD's forecast from analysts indicates a "Hold", our proven Zen Rating quant model rates THRD as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their THRD stock forecasts and price targets.

THRD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-03-28
lockedlocked$00.00+00.00%2025-02-12

1 of 1

Forecast return on equity

Is THRD forecast to generate an efficient return?

Company
-16.06%
Industry
140.91%
Market
90.47%
THRD's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is THRD forecast to generate an efficient return on assets?

Company
-15.64%
Industry
32.45%
THRD is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

THRD earnings per share forecast

What is THRD's earnings per share in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$0.86
Avg 2 year Forecast
-$0.94
Avg 3 year Forecast
-$0.98

THRD revenue forecast

What is THRD's revenue in the next 2 years based on estimates from 2 analysts?

Avg 1 year Forecast
$14.2M
Avg 2 year Forecast
$8.0M

THRD vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
THRD$5.43$5.00-7.92%Hold
PROK$0.84N/AN/A
LXRX$0.67$3.67+446.50%Buy
DBVT$9.10$14.81+62.78%Hold
FHTX$4.32$11.80+173.15%Strong Buy
View Top Biotech Stocks

Third Harmonic Bio Stock Forecast FAQ

Is Third Harmonic Bio Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: THRD) stock is to Hold THRD stock.

Out of 2 analysts, 0 (0%) are recommending THRD as a Strong Buy, 0 (0%) are recommending THRD as a Buy, 2 (100%) are recommending THRD as a Hold, 0 (0%) are recommending THRD as a Sell, and 0 (0%) are recommending THRD as a Strong Sell.

If you're new to stock investing, here's how to buy Third Harmonic Bio stock.

What is THRD's earnings growth forecast for 2025-2027?

(NASDAQ: THRD) Third Harmonic Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 10.6%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.33%.

Third Harmonic Bio's earnings in 2025 is -$53,447,000.On average, 1 Wall Street analyst forecast THRD's earnings for 2025 to be -$38,809,905, with the lowest THRD earnings forecast at -$38,809,905, and the highest THRD earnings forecast at -$38,809,905. On average, 1 Wall Street analyst forecast THRD's earnings for 2026 to be -$42,420,129, with the lowest THRD earnings forecast at -$42,420,129, and the highest THRD earnings forecast at -$42,420,129.

In 2027, THRD is forecast to generate -$44,225,241 in earnings, with the lowest earnings forecast at -$44,225,241 and the highest earnings forecast at -$44,225,241.

What is THRD's revenue growth forecast for 2030-2031?

(NASDAQ: THRD) Third Harmonic Bio's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 56.38%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.68%.

Third Harmonic Bio's revenue in 2025 is $0.On average, 2 Wall Street analysts forecast THRD's revenue for 2030 to be $641,942,912, with the lowest THRD revenue forecast at $606,968,870, and the highest THRD revenue forecast at $676,916,955.

In 2031, THRD is forecast to generate $361,022,376 in revenue, with the lowest revenue forecast at $361,022,376 and the highest revenue forecast at $361,022,376.

What is THRD's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: THRD) forecast ROA is -15.64%, which is lower than the forecast US Biotechnology industry average of 32.45%.

What is THRD's Price Target?

According to 2 Wall Street analysts that have issued a 1 year THRD price target, the average THRD price target is $5.00, with the highest THRD stock price forecast at $5.00 and the lowest THRD stock price forecast at $5.00.

On average, Wall Street analysts predict that Third Harmonic Bio's share price could fall to $5.00 by Mar 28, 2026. The average Third Harmonic Bio stock price prediction forecasts a potential downside of 7.92% from the current THRD share price of $5.43.

What is THRD's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: THRD) Third Harmonic Bio's current Earnings Per Share (EPS) is -$1.23. On average, analysts forecast that THRD's EPS will be -$0.86 for 2025, with the lowest EPS forecast at -$0.86, and the highest EPS forecast at -$0.86. On average, analysts forecast that THRD's EPS will be -$0.94 for 2026, with the lowest EPS forecast at -$0.94, and the highest EPS forecast at -$0.94. In 2027, THRD's EPS is forecast to hit -$0.98 (min: -$0.98, max: -$0.98).

What is THRD's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: THRD) forecast ROE is -16.06%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.